{"name":"Aspa Therapeutics","slug":"aspa-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQS2E0RVh5TDRmVEV5WUVDUkRGS3BjZ09ZWFhCYmNvaThaNGx3RXE3ektZVmtMWWd3ZUMyaGpEZkN0YzZZT3NHVjhKdGZYSERfWlZOdlpTNW1hRlBEU3l0ZEdZV0VXMTNEZG1BeHY3V1Y1S3BJUDV6bHMyNzRENXVvSDc1UWE2VlJyNVJuRVB2Y2VZOHVJUGV0allSd1M?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Adeno-Associated Viral Vectors Market - openPR.com","headline":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Adeno-Associated Viral Vectors Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxPSW5wY1JiYjdiVmxOeXdKRzFFUDY2UDZwZUJvVEprdUFybWNibU5QR3BwTnh2VWZxVE5Ba1ptQ0JCa0VQNjdGSGpDbjdyUlJycTJNaEphMzVPYTlMRGtOVm5NNS1NcWo0Mno4SDdzVHN3ZF9rYXZtclNSVHBObWFqUWExOVRGOUhRZ1Z3XzRZc01Bb3VwdU1oYXo0TXFuS3pqV3VReHhiTkdlMEJqQWtDZHdSUWFrQ21wcHdsamNEbVlobnF3S0xicWl0V3luV2lVeVcwejdCeTB1dGtiNjZlWlBfRm52azRfLVZLZXZBanNzUjZwNENmdjY5OVdmVFY1cEJfY01Zam5xLUJheFhld3VreUs?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Ma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOR0dXN0FNeGhOTkdSZi1OLVgxTHIwTmVrOWF4ZER5LVpwZ3NpekxwVUZGbERnLV92NTFTdGszWEFjN0dUNmp3dWk4UW9wYjZuLVQ1d2FoYkVyS3llX09Dc0pmRWFrQTB1N3hWN081VU5zU2tHUGFIS0RBakpWRkFqLUJiQUJISmtyWGZRQlVES296QmFsNE45TWktNzFvRWtncDk1ckJBWko2c3V5dDJrd2tVN1l1cUI3NTNoQ2hBZjh1SWxUanRmVk1BUlhjZw?oc=5","date":"2025-10-13","type":"pipeline","source":"CGTLive®","summary":"Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume - CGTLive®","headline":"Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume - C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQTTNmSUJ2am01RjFaek51eEw2ak04eUVNeVQ2ZXI4MDNUUXNBam05TXhaRGZoU3YzWFNDZHk3Z2wwUVBncDFDbi0wWmJONm51dE5nTTBfNzJ1ZWRoc0lZVFlvRm5jd1VveG5fMHRYSDlSdkdBM2NGREhXR185WVhzSW9EMExBTGQ2ZVppRkt3eE8wUWdVNGoySzdiWUJHUHpka1pTMmZvSVdHOGJEcGpSbkhzQVluajVKTHNULVFuOGY0ZExuRkM3aDlLSkFHNTZJeHBqUldPWEdPRzdjcXo3Ulg5UHJiMXI0ajdYcjFaQ3JONk0yR2kxZkpJN2NwU1NOQl9vUU41cjNWSnpYOXF4dTZUSVRsRnpDLW9nMXJac0tER1gtaVBpRVNMRGRaX3M0aVRIS1JnUk4tMmdEakxJ?oc=5","date":"2025-10-06","type":"trial","source":"PR Newswire","summary":"Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa - PR Newswire","headline":"Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQZHE2a0laLXJGX0RuXzNNcDJlenJoNENtOFRHdXJWZW9RbGh1YkdTdVQ5NWNDZHlvVllnNUhEb20ya1FnZUVFWkhOVUoxYmVBSTFLNnh3OHRhNERsXy1Tek04b0dsUmVNd2k0RzhwUXp6OWpKX051ejhMdXdKYWZySkF3WXRKNnZhX2R4R0ExeWJLRmdnQTB1RlQwVGNvMkZ2VlNWeTBNX0cydG5vcnVrYkRzMEZLckRfY3huUWJfWGp2WF96RXA5ZFI4Y2FYbTVnVS0zY3dZOTRxZEZYQUZKYXd4UWp6c2l3N1JRTWRETVU4RjJiY2dUMVJFbE1MYUY1eEhFRXJRUFVMWXEzMjZHNG5xWTZ0V2w1ZWtONThsOExJWEtLbHVQek9ITnBVaVNtNFkxX0JiTVYtMmhUemhsOWNLaW0wYkk?oc=5","date":"2025-09-16","type":"trial","source":"PR Newswire","summary":"Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease - PR Newswire","headline":"Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational G","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5wb1RGNzVidl9iZk5tYzk3SWMwUF9SZUttMFlVT0hXMHJTb244cmdaVnhnOW1RQi1QQjhkb3dzSGE3eVUzZTRTSDBBMzBBT0hkUVd1dUd3RVB3ZWpXX0dKU0tKeGYzakpDT0c1b0F0UG0wSGI4MEsyS21TWjBWczTSAYQBQVVfeXFMUEJpbWl6ZkU2SUpMLUxTYTM4TE1zSG9xS3l5eDBJQzY0WUtmTVdyYkxlY3dHR1BudDdoSkliVVVHNGJzVU1ZaWtSVjVaN3YzMTUxcVJUV1V5dm9nck5NZnd6emlDUDNfX3ktTzZBdjE3V3NlRC1TcWYxVlFYeGsyOElJRjRl?oc=5","date":"2025-09-16","type":"pipeline","source":"Express Pharma","summary":"ASPA elects new governing body for 2025–2027 - Express Pharma","headline":"ASPA elects new governing body for 2025–2027","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-05","type":"trial","source":"GlobeNewswire","summary":"AAV for the Hereditary Retinal Diseases Clinical Trial - GlobeNewswire","headline":"AAV for the Hereditary Retinal Diseases Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxORWFlbUVCSHF3MHpyN2k3QU9OYXV6OTNWZi1CTFE1YkJvd3lNRjRCQ04teDVuTW1ITnN4d0VTelhiNjI4Z3l5SEwyV04tS2dpZ2hjdkNtVTBTOXljdHlmaG10WGRISllhMTdWa0EtUklSWllIUXROYk83ZVZxS0hOcUFGb0IxcDYtLWw2bGp3OTBTanIySmtMU1dpSTFpYzNHbFZ2elFQdmNaUEFhalhqdXBSUmlaNEhxbHl2aDNjc2NibVFXRVlBQXJkTWMtQ1p6ZVVuXzE5OFJ1MlpoMl9TVmlEZUVueUtKbUZPUzhlOFM0cG11cVNwT1p6LVhnUE1SeFV3TjExNlpOMFR1V2YwdkFFQUpyZmVlT19uMDZGeGxBeHpURHNOcEQ5WVRMM2Uya3dfRnQtb3E?oc=5","date":"2025-01-31","type":"pipeline","source":"BioSpace","summary":"Hereditary Central Nervous System Demyelinating Diseases Market Predicted to Grow at a CAGR of 9.71% during 2025-2035, Impelled by Advancements in Genetic Research & Diagnostics - BioSpace","headline":"Hereditary Central Nervous System Demyelinating Diseases Market Predicted to Grow at a CAGR of 9.71% during 2025-2035, I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNSXZWNERmUkREUE9yYVFzMGJhZ2tqcEM2dmZtZUx6THpZejN1dExuVzMyMExQMUVYT1NDcEZxWFhuTFZSaVZCWFk5ZllSdm1Hei1QWHUxbkF5WEJEMVFTWTZOc0pQZUd0YVpDUjZJaHhUV2tVZWpTODRwaVRzQnZ5RU90dHB5eGl3TTg5cUdPSXZzRkszOWl0MTFyNFc1RE1WN0xVT045aWloNWRUTVQxVHZyQnRndmJJbThLamZkY01mczVPQmE2clMyd0QtZjFDSFVjQQ?oc=5","date":"2024-10-30","type":"pipeline","source":"CGTLive®","summary":"BridgeBio Pharma’s Gene Therapy BBP-812 Effects Progressive Improvement in Motor Function in Patients With Canavan Disease - CGTLive®","headline":"BridgeBio Pharma’s Gene Therapy BBP-812 Effects Progressive Improvement in Motor Function in Patients With Canavan Disea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxORC1zUlItRUxxZ1VPdFhsZ0w2dlQ1NVJsRmRLOXJGOFl1bDA3SDFFNmpjUjhoYVdXc2tKc3J0dW9HV0kzNHQ0MkI5QnlEZmUyVTdSc0NyNnROSWVfbFItMTFIcjBnZVBUTkJiTU9QbWFNYWR0Nk5wVEs0cmZoWUk0TWZxQzBMRlpycjFoVzBuX1JaSUYwX05ILWJlc2ZaV2RNUWZHd1czQTZEMTdYd3VwekxqcDUtWjBCZmNCcHBmZkthbUVfdThwR3ZWV2xtUmxLQlBWRg?oc=5","date":"2024-10-28","type":"trial","source":"Inside Precision Medicine","summary":"Yes, We Can: BridgeBio Shares Positive Gene Therapy Data in Canavan Trial - Inside Precision Medicine","headline":"Yes, We Can: BridgeBio Shares Positive Gene Therapy Data in Canavan Trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQNzlWWjE3OUJoaDFsb3BQMzl6SkxKcEg2Y3c5Z0l5R1g0Z3BPUzhDOHlGbjZtMk5VdFlQWkVPNEluY1poWk5pRWtxYnpBSWVmTHhuQ2dLTC12UE1TYTVOaUt3dUEzSTloT1Q5QnY5ai1zaFNHY0s3VXlfUWYtV2p6OE5nM1BUeVlYZVVPbHY3N0syQ0wybkVJTzNkamZuMkJvdVIwZVRQTG1Ld2hfcnBWUnpoeHdfc3BzY2lMUzZwV2ZVVFZmUDdVdERERQ?oc=5","date":"2024-10-02","type":"trial","source":"CGTLive®","summary":"Myrtelle’s Canavan Disease Gene Therapy rAAV-Olig001-ASPA Decreases N-Acetylaspartate Levels in Phase 1/2 Study - CGTLive®","headline":"Myrtelle’s Canavan Disease Gene Therapy rAAV-Olig001-ASPA Decreases N-Acetylaspartate Levels in Phase 1/2 Study - CGTLiv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPUEhDZUUtTE9DTERHZHU1MEs0WXJqbGVNUnAwWUQ1RXhlVnZSWVMyZHRsV2Vic2JaQ1l1LWZFYmFwbHZleEViSHVjTEFfeEZEYVA0WDdLelVIcW1iSlRqOFYtX3pfQlBNQWRXU2RYdUpVS2NXWU9jQVU3MmtBY2dnLWpnd0lMUkhTa1NJd21XR253M0FVd1pVUFB0QW1vU2oxczR0bTJkRjNJYmpkZXc1bm9IUUZseV9URkJiMExSWHk3ZDNNSDFRazhKTk5fcGN3SDZoc19vR1hGeVUwNS00NzAyMFZCRVlESm4xekVpNA?oc=5","date":"2022-11-08","type":"trial","source":"umassmed.edu","summary":"NTSAD to honor Guangping Gao for lifetime work on Canavan disease, as gene therapy trial shows promise - umassmed.edu","headline":"NTSAD to honor Guangping Gao for lifetime work on Canavan disease, as gene therapy trial shows promise","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}